Quarter
Charts

INDIVIOR PHARMACEUTICALS, INC.

INDV

CIK 0001625297 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$358M
↑+19.7% +$59Mvs FY2024 (Q4)
Operating Income
$81M
↑+76.1% +$35Mvs FY2024 (Q4)
Net Income
$81M
↑+285.7% +$60Mvs FY2024 (Q4)
Gross Profit
$291M
↑+16.1% +$40Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Strong
76/100
  • Profitability
    100ROIC 270.8% (10% = solid, 20%+ = moat)
  • Liquidity
    11Current Ratio 0.71 (above 1.5 = solid)
  • Leverage
    100D/E -2.96 (under 0.5 = conservative)
  • Efficiency
    60Asset Turnover 0.98x (1.0+ = capital-efficient)
  • Growth
    82Revenue YoY +19.7% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin 22.6% · trend +17.8pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$66M
investment in PP&E
Stock buybacks (TTM)
$11M
share count reduction
Stock-based comp (TTM)
$26M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$1.20B
everything owned
Total liabilities
$1.30B
everything owed
Stockholders' equity
$-98M
shareholder claim
Net debt
$95M
LT debt minus cash

Recent performance · 11 quarters

Revenue↑+19.7% +$59M
$358M
Net Income↑+385.7% +$81M
$102M
Free Cash Flow↓-50.0% -$8M
$-24M
Operating Margin↑+7.2pts
22.6%

Drill down

INDV Sankey

See INDIVIOR PHARMACEUTICALS, INC.'s revenue flow into every line item of the income statement and balance sheet — every dollar accounted for, with prior-period comparison.

Open Sankey

INDV Charts

11 quarters of historical line items — Income, Cash Flow, Balance Sheet, plus margins. Click any chart for the trend dialog.

Open Charts

INDV Key Metrics

EPS, BVPS, FCF/Share, ROE, ROA, ROIC, D/E, Current Ratio, Quick Ratio, Asset Turnover — 10 CFA-grade fundamentals derived from EDGAR data.

Open Key Metrics